Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren's syndrome.
Gwenny M VerstappenLisette de WolffSuzanne ArendsHella-Marie HeiermannYannick van SleenAnnie VisserJanneke H TerpstraDimitri A DiavatopoulosMarieke van der HeidenArjan VissinkDebbie van BaarleFrans G M KroeseHendrika BootsmaPublished in: RMD open (2022)
Patients with pSS had similar humoral and cellular immune responses as HC, suggesting COVID-19 vaccination is effective in patients with pSS. AEs were also comparable, and no increase in disease activity was seen in patients with pSS.